Arca
Skip to content

Heel Stick Safety Lancet (HHZ-II, HHZ-III, HHZ-IV)

Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature. 510(k) K252490, from Tianjin Huahong Technology Co., Ltd. (Tianjin, CN). Product code FMK, class 2.

As of Nov 17, 2026, K252490 is an FDA 510(k) held by Tianjin Huahong Technology Co., Ltd., substantially equivalent on Feb 12, 2026 after 188 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Feb 12, 2026
  • Review time: 188 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Heel Stick Safety Lancet is intended for the collection of capillary blood from the heel of newborn, preemie, and toddler. The lancet has equipped with safety protection features.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other FMK Clearances

The newest 510(k)s for the same product code; their median review was 59 days; see every FMK device

Record

Type
Special
Received
Aug 8, 2025
Review panel
General, Plastic Surgery
Regulation
21 CFR 878.4850

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.